Clinical Trial Update: Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether diacerein (Diacerhein) modulates synovial fluid inflammatory mediators in knee osteoarthritis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Diacerhein (diacerein)

Snippet

Sponsor: Laboratoires NEGMA | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED